Insights on Treating HCV-Related B Cell Non-Hodgkin Lymphoma
The risk to develop B-cell Non-Hodgkin Lymphoma (B-NHL) increases in chronic Hepatits C (HCV), molecular mechanisms are poorly understood. The most common NHL subtypes in this setting are Marginal Zone Lymphoma and Diffuse Large B-cell Lymphoma (DLBCL). In Brazil, we lack epidemiologic and clinical evidence in this scenario.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Ana Pittella, Elias Atta, Leonardo Gomes, Clarissa Cavalin Silva, Ana Ang élica Pimenta Source Type: research
More News: Chronic Leukemia | Epidemiology | Hematology | Leukemia | Lymphoma | Myeloma | Non-Hodgkin's Lymphoma